10 Best Biotech Stocks to Invest In According To Billionaire Biotech Hedge Fund
In this article, we will present the 10 best stocks to invest in according to the billionaire biotech hedge fund manager Joe Edelman. Click to skip ahead...
Posts Tagged ‘NASDAQ:CYTK’
Top 10 Healthcare Stocks To Buy for the Future
In this article we present the list of Top 10 Healthcare Stocks To Buy for the Future. Click to skip ahead and see the Top 5 Healthcare Stocks for the...
Hedge Funds Keep Buying Cytokinetics, Inc. (CYTK)
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings...
Did Hedge Funds Make The Right Call On Cytokinetics, Inc. (CYTK) ?
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (...
Hedge Funds Have Never Been This Bullish On Cytokinetics, Inc. (CYTK)
In this article you are going to find out whether hedge funds think Cytokinetics, Inc. (NASDAQ:CYTK) is a good investment right now. We like to check...
Is Cytokinetics, Incorporated (CYTK) A Good Stock To Buy?
We at Insider Monkey have gone over 752 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the...
Here is What Hedge Funds Really Think About Cytokinetics, Incorporated (CYTK)
We are still in an overall bull market and many stocks that smart money investors were piling into surged through October 17th. Among them, Facebook and...
Hedge Fund and Insider Trading News: Michael Platt, Warren Buffett, Balyasny Asset Management, AQR Capital, Aspen Group Inc (ASPU), W&T Offshore, Inc. (WTI), and More
Balyasny Gains in First Half After Losses Prompted Reorganization in 2018 (Reuters) BOSTON (Reuters) – Balyasny Asset Management, a Chicago-based...
Did Hedge Funds Drop The Ball On Cytokinetics, Inc. (CYTK) ?
Hedge fund interest in Cytokinetics, Inc. (NASDAQ:CYTK) shares was flat at the end of last quarter and it wasn’t that high to begin with. This is...
Hedge Funds Are Dumping Cytokinetics, Inc. (CYTK)
It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment...
13G Filing: Biotechnology Value Fund LP and Cytokinetics Inc (CYTK)
Cytokinetics Inc (NASDAQ:CYTK): Mark Lampert’s Biotechnology Value Fund LP filed an amended 13D. You can check out Biotechnology Value Fund LP&#...
13G Filing: Biotechnology Value Fund LP and Cytokinetics Inc (CYTK)
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 13 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE...
Here’s What You Should Know About The Finance World Today
1. US Stock Market: “U.S. stocks retreated on Tuesday as a spate of tepid corporate earnings weighed on the broader market. The Dow Jones...
Cytokinetics, Inc. (CYTK) Hedge Funds Are Snapping Up
Looking for high-potential stocks? Just follow the big players within the hedge fund industry. Why should you do so? Let’s take a brief look at what...
Cytokinetics Inc (CYTK): Mark Lampert’s Biotechnology Value Fund Loads Up On More Shares
Mark Lampert‘s Biotechnology Value Fund has filed a Form 13G on Cytokinetics, Inc. (NASDAQ:CYTK), one of its top-10 holdings at the end of 2015...
Hedge Funds Are Buying Cytokinetics, Inc. (CYTK)
Before we spend many hours researching a company, we’d like to analyze what hedge funds and billionaire investors think of the stock first. We would...
Cytokinetics, Inc. (CYTK) Conference Call Transcript – Expansion of Collaboration Agreement with Astellas
Below is the Cytokinetics, Inc. (NASDAQ:CYTK) conference call transcript regarding the expansion of collaboration agreement with Astellas held on Monday...
New Changes in SAC Capital’s 13F Portfolio: Annies Inc (BNNY), Cytokinetics, Inc. (CYTK) And Other
In another round of filings with the Securities and Exchange Commission, Steven Cohen and his fund, SAC Capital Advisors, have disclosed 4 new moves:...
Mark Lampert, Biotechnology Value Fund Up Stake In Cytokinetics, Inc. (CYTK), Reduce Exposure To Regado Biosciences Inc (RGDO)
Mark Lampert, the founder and manager of Biotechnology Value Fund, is bullish on Cytokinetics, Inc. (NASDAQ:CYTK). According to a recent filing with...
Hedge Funds Are Selling BioDelivery Sciences International, Inc. (BDSI)
Is BioDelivery Sciences International, Inc. (NASDAQ:BDSI) a good investment? At the moment, there are many indicators market participants can use to...
This Metric Says You Are Smart to Buy Amicus Therapeutics, Inc. (FOLD)
Is Amicus Therapeutics, Inc. (NASDAQ:FOLD) a good investment? Now, according to many investors, hedge funds are assumed to be overrated, outdated investment...
Aegerion Pharmaceuticals, Inc. (AEGR): Cheers and Jeers for Amgen, Inc. (AMGN)’s Pipeline
Just after the successful acquisition of Onyx Pharmaceuticals and positive results on AMG-145, a cholesterol-lowering experimental drug, Amgen, Inc...
Cytokinetics, Inc. (CYTK), Amgen, Inc. (AMGN): Digging Deeper Into This Heart Failure Drug’s Miss
Before the market opened last Tuesday, Cytokinetics, Inc. (NASDAQ:CYTK) and Amgen, Inc. (NASDAQ:AMGN) scrambled to spin the results of their Phase 2...
Astex Pharmaceuticals, Inc. (ASTX), GlaxoSmithKline plc (ADR) (GSK), Cytokinetics, Inc. (CYTK): Last Week in Biotech
With the SPDR S&P Biotech Index up 38% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into...
MiMedx Group Inc (MDXG), Cytokinetics, Inc. (CYTK), Amgen, Inc. (AMGN): A Trio of Horrendous Health-Care Stocks This Week
College football arrived in a big way over the past week or so, with plenty of big plays already. Health-care stocks had their fair share of big plays...
Pain Therapeutics, Inc. (PTIE): Are Hedge Funds Right About This Stock?
Should Pain Therapeutics, Inc. (NASDAQ:PTIE) investors track the following data? In the eyes of many investors, hedge funds are viewed as overrated,...
What Hedge Funds Think About ArQule, Inc. (ARQL)
Is ArQule, Inc. (NASDAQ:ARQL) a good investment? In the 21st century investor’s toolkit, there are many metrics shareholders can use to monitor stocks...
Celgene Corporation (CELG), Cytokinetics, Inc. (CYTK), Astex Pharmaceuticals, Inc. (ASTX): Is the Biotech Bubble About to Burst?
“Bubble” can be a provocative word in investing circles. Think of all that comes to mind when you hear it — perhaps other words like...
What’s a Smart Cytokinetics, Inc. (CYTK) Investor To Do?
What’s a smart Cytokinetics, Inc. (NASDAQ:CYTK) investor to do? In the eyes of many of your peers, hedge funds are seen as useless, old investment...
Clovis Oncology Inc (CLVS), ACADIA Pharmaceuticals Inc. (ACAD): Healthcare Companies to Watch Out For
Healthcare is the most happening industry these days with new drugs on the line and investors injecting cash into companies with greater speculative growth...
Cytokinetics, Inc. (CYTK), Exelixis, Inc. (EXEL): Three Small Cap Biotech Stocks with Great Potential
Small cap stocks are a bit riskier, but offer more growth than the stable large cap ones. The biotech sector in U.S. has a number of small cap stocks...
Celldex Therapeutics, Inc. (CLDX), Cytokinetics, Inc. (CYTK): Are These Top Biotech Performers Still Worth Buying?
Only a handful of stocks have gained 200% in 2013, and five of those stocks are in the biotechnology industry. Perhaps you already own one, or maybe...
OncoGenex Pharmaceuticals Inc (OGXI): Are Hedge Funds Right About This Stock?
Is OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI) a cheap investment today? Money managers are getting more bullish. The number of long hedge fund bets improved...
Cytokinetics, Inc. (CYTK): Hedge Funds Are Bullish and Insiders Are Bearish, What Should You Do?
Cytokinetics, Inc. (NASDAQ:CYTK) was in 8 hedge funds’ portfolio at the end of March. CYTK shareholders have witnessed an increase in support from...
Hedge Funds Are Crazy About Cytokinetics, Inc. (CYTK)
Is Cytokinetics, Inc. (NASDAQ:CYTK) the right pick for your portfolio? Prominent investors are in a bullish mood. The number of bullish hedge fund bets...
Hedge Funds Are Buying Amicus Therapeutics, Inc. (FOLD)
Amicus Therapeutics, Inc. (NASDAQ:FOLD) was in 12 hedge funds’ portfolio at the end of March. FOLD shareholders have witnessed an increase in enthusiasm...
Is BioDelivery Sciences International, Inc. (BDSI) Going to Burn These Hedge Funds?
BioDelivery Sciences International, Inc. (NASDAQ:BDSI) shareholders have witnessed a decrease in hedge fund sentiment of late; stagnant interest is a...
Pain Therapeutics, Inc. (PTIE): Are Hedge Funds Right About This Stock?
Is Pain Therapeutics, Inc. (NASDAQ:PTIE) a buy, sell, or hold? The smart money is in a bearish mood. The number of long hedge fund positions were trimmed...
Amgen, Inc. (AMGN), Cytokinetics, Inc. (CYTK): A New Approach to Treating a Broken Heart
A failing heart is a lot like a glass Heinz Ketchup bottle. Squeezing the bottle isn’t very efficient, so you smack that strategically placed &#...
Hedge Funds Aren’t Crazy About Cytokinetics, Inc. (CYTK) Anymore
Cytokinetics, Inc. (NASDAQ:CYTK) has seen a decrease in hedge fund interest in recent months. In today’s marketplace, there are a multitude of indicators...
Amicus Therapeutics, Inc. (FOLD): Are Hedge Funds Right About This Stock?
Is Amicus Therapeutics, Inc. (NASDAQ:FOLD) a marvelous investment today? Money managers are becoming less confident. The number of bullish hedge fund...
Enzon Pharmaceuticals, Inc. (ENZN): Are Hedge Funds Right About This Stock?
Is Enzon Pharmaceuticals, Inc. (NASDAQ:ENZN) a buy, sell, or hold? The best stock pickers are taking a bearish view. The number of long hedge fund positions...
Zynga Inc (ZNGA), Cytokinetics, Inc. (CYTK), and More: 3 Stocks That Blew the Market Away
Don’t settle for ordinary quarterly reports. Every week, I take a look at three companies that beat market expectations, since I believe that it...
